Skip to main content
. 2023 Feb 2;16:1081580. doi: 10.3389/fnins.2022.1081580

FIGURE 2.

FIGURE 2

The anti-GAD antibody titers decreased after immunotherapy in 14 patients. The dashed lines represents the high-titer group. Serum anti-GAD antibodies in the high-titer group (n = 6) showed a median reduction of 86% (range 58–99%). The median titer reduction in the low-titer group (n = 8) was 95% (range 36–99%). GAD, glutamic acid decarboxylase.